GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (STU:8IM1) » Definitions » Additional Paid-In Capital

Implantica AG (STU:8IM1) Additional Paid-In Capital : €0.00 Mil(As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Implantica AG Additional Paid-In Capital?


Implantica AG Additional Paid-In Capital Historical Data

The historical data trend for Implantica AG's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Implantica AG Additional Paid-In Capital Chart

Implantica AG Annual Data
Trend
Additional Paid-In Capital

Implantica AG Semi-Annual Data
Additional Paid-In Capital

Implantica AG Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Implantica AG Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Implantica AG's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Implantica AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Implantica AG (STU:8IM1) » Definitions » Additional Paid-In Capital
Comparable Companies
Traded in Other Exchanges
IMP A SDB:Sweden 8IM1:Germany
Address
Aeulestrasse 45, Vaduz, LIE, 9490
Website
https://www.implantica.com
Implantica AG is a medtech group providing effective care for serious health conditions and improving patients' quality of life by bringing advanced technology into the body. The therapies Implantica develops are based on implants that are medical devices inserted into the patient's body and are intended to remain in place permanently or semi-permanently, using electrical power provided by a battery. The company has developed a broad, patent-protected, product pipeline based partly on its two platform technologies. Its lead product, RefluxStop, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by successful clinical trial results.

Implantica AG Headlines

No Headlines